Company Overview
About Ginkgo Bioworks
Ginkgo Bioworks is a synthetic biology platform company that provides cell programming services to the agricultural, pharmaceutical, food, and industrial chemicals industries, helping customers design and manufacture biological products using engineered microorganisms. Founded in 2008 by MIT researchers and headquartered in Boston, Ginkgo went public via SPAC merger in September 2021 at a $15 billion valuation — one of the largest biotech-related SPAC transactions ever.
Business Model & Competitive Advantage
Ginkgo's platform combines automated biology labs (called Foundries), proprietary genetic parts libraries (the Codebase), and data analysis to dramatically reduce the cost and time to engineer cells for industrial applications. Customers pay Ginkgo to design strains that produce target compounds — enzymes, proteins, novel molecules — using a platform fee plus royalty model. The company has collaborated with Bayer (agriculture), Sumitomo Chemical, Ginkgo Crop Protection, and defense agencies on biological manufacturing programs.
Competitive Landscape 2025–2026
In 2025, Ginkgo has undergone significant restructuring after its SPAC valuation proved unsustainably high relative to revenue growth. The company announced major layoffs of over 50% of its workforce in 2023-2024 and sold or wound down several subsidiary businesses to reduce cash burn. Revenue has been concentrated in government biosecurity contracts (Ginkgo Biosecurity) rather than commercial synthetic biology, raising questions about the commercial viability of its original platform vision. Ginkgo's 2025-2026 survival strategy focuses on right-sizing costs, expanding government biosecurity revenue, and identifying the core platform capabilities worth preserving.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Ginkgo Bioworks is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare Ginkgo Bioworks with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Ginkgo Bioworks? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Ginkgo Bioworks Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Ginkgo Bioworks vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →